COM:OSE-IMMUNO
Ose Immunotherapeutics
- Privately Held
news impact assignment basic | general | |||||
public peers | general | Sep 10, 2024 10:12 AM | ddbd1678 | |||
news daily refresh | general | |||||
news processing daily refresh | general | |||||
news impact assignment daily | general | |||||
news processing basic | general | Sep 10, 2024 10:38 AM | bf43728f | |||
company summary | general | |||||
signals | general | Sep 10, 2024 10:12 AM | 49667abb | |||
crunchbase trigger | general | Nov 12, 2024 12:52 PM | 13ad891d | |||
crunchbase profile | general | Nov 12, 2024 2:23 PM | 7a8df44d | |||
li profile | general | |||||
translate crunchbase fundingrounds | general | Nov 12, 2024 2:40 PM | 24828341 | |||
peers | general | Sep 10, 2024 10:12 AM | e628312f | |||
news basic | general | Sep 10, 2024 10:12 AM | 7f146332 | |||
bundesanzeiger | filings | |||||
financials download nd | financials | |||||
private financials | financials |
243cc1e2-f6e1-41f2-b8ef-4aff37233327